• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Practical considerations regarding the use of total nutrient admixtures.

作者信息

Driscoll D F, Baptista R J, Bistrian B R, Blackburn G L

出版信息

Am J Hosp Pharm. 1986 Feb;43(2):416-9.

PMID:3082199
Abstract

The biological concerns, proper storage and administration, and advantages of using total nutrient admixtures (TNAs) for nutritional support are reviewed. In 1983, FDA approved lipid emulsions for administration with dextrose and selected crystalline amino acid preparations (known as three-in-one or total nutrient admixtures). The stability of TNAs is affected by pH, order of mixing, and temperature. Conflicting results have been reported on the issue of microbial growth potential in TNAs. At room temperature, the delivery of the TNA infusate should not exceed 24 hours. Plastic containers that do not contain diethylhexyl phthalate, in sizes up to 3 L, are practical and safe for administration of TNAs. The efficiency of an institution's volumetric pumps should be evaluated before converting to a TNA system because the low final concentrations of lipid emulsion present in the admixtures may render certain pumps inoperable. The practical, nutritional, and potential economic benefits of a TNA delivery system support its use. Further research is needed to determine microbial growth potential, electrolyte and drug compatibilities, and stability under prolonged storage of these admixtures.

摘要

相似文献

1
Practical considerations regarding the use of total nutrient admixtures.
Am J Hosp Pharm. 1986 Feb;43(2):416-9.
2
Stability of Liposyn II fat emulsion in total nutrient admixtures.力扑素II脂肪乳剂在全营养混合液中的稳定性。
Am J Hosp Pharm. 1986 May;43(5):1230-5.
3
Stability of total nutrient admixtures in a dual-chamber flexible container.双腔软袋中全营养混合液的稳定性
Am J Hosp Pharm. 1990 Nov;47(11):2496-503.
4
Effect of various nutrient ratios on the emulsion stability of total nutrient admixtures.不同营养比例对全营养混合液乳剂稳定性的影响。
Am J Hosp Pharm. 1986 Dec;43(12):3017-22.
5
Stability of famotidine 20 and 50 mg/L in total nutrient admixtures.法莫替丁在20毫克/升和50毫克/升总营养混合液中的稳定性。
Am J Hosp Pharm. 1989 Nov;46(11):2326-9.
6
Stability of nizatidine in total nutrient admixtures.尼扎替丁在全营养混合液中的稳定性。
Am J Hosp Pharm. 1991 Jul;48(7):1507-10.
7
Fat emulsion particle-size distribution in total nutrient admixtures.全营养混合液中脂肪乳剂的粒径分布
Am J Hosp Pharm. 1992 Nov;49(11):2749-55.
8
Stability of total nutrient admixtures using various intravenous fat emulsions.
Am J Hosp Pharm. 1987 Oct;44(10):2271-80.
9
Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging.玻璃包装与塑料包装的全营养混合液与脂肪乳注射液的稳定性
Am J Health Syst Pharm. 2007 Feb 15;64(4):396-403. doi: 10.2146/ajhp060062.
10
Stability of MCT/LCT-based total nutrient admixtures for neonatal use over 30 hours at room temperature: applying pharmacopeial standards.室温下基于 MCT/LCT 的新生儿全营养混合液在 30 小时内的稳定性:应用药典标准。
JPEN J Parenter Enteral Nutr. 2010 May-Jun;34(3):305-12. doi: 10.1177/0148607109338215.

引用本文的文献

1
Total parenteral nutrition 1990. A review of its current status in hospitalised patients, and the need for patient-specific feeding.全胃肠外营养1990。住院患者中其现状的综述以及个性化喂养的必要性。
Drugs. 1990 Sep;40(3):346-63. doi: 10.2165/00003495-199040030-00003.